![]() | This article has not yet been rated on Wikipedia's content assessment scale. |
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about UR-144.
|
This page should not be speedy deleted because...
editThis page should not be speedily deleted because it's page about chemical substance --Vasiliy 100 (talk) 06:49, 4 November 2011 (UTC)
Requested move
edit- The following discussion is an archived discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. No further edits should be made to this section.
The result of the move request was: page moved. If anyone thinks that this should have been closed as no consensus, then this move is still correct since it reverses an undiscussed move from UR-144. If anyone wishes to move this, open a new discussion with verifiable sources that support the proposed name is the common name. Vegaswikian (talk) 21:29, 11 March 2012 (UTC)
KM X-1 → UR-144 – Relisted. Favonian (talk) 11:36, 4 March 2012 (UTC). Dipankan001 had a good point in that the old name for this article was rather long and technical, but the page was moved to a random vendor's name rather than the commonly accepted trade name, UR-144. Enix150 (talk) 23:55, 25 February 2012 (UTC)
- It's already a redirect, so need of the move. If you type UR-144, then the article (1-Pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone comes; although the title remains KM-X1. Dipankan In the woods? 07:09, 26 February 2012 (UTC)
- This is true, but Wikipedia policy states that we should use the common name for an article's title. Plus KM X-1 will still redirect to the article after the move. Enix150 (talk) 11:49, 27 February 2012 (UTC)
- The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page. No further edits should be made to this section.